CROX vs DVA · rev $4.10B vs P/E 14, rev $12.82B
Crocs Inc (CROX) versus DaVita HealthCare Partners Inc (DVA) — a side-by-side from cached financials, not a winner call.
Crocs Inc (CROX) is a footwear & accessories company listed on US.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Latest reported CROX revenue for 2024-12-31 was $4.10B. Net income was $950.1M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. CROX currently screens at market cap $5.93B.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
CROX currently screens at market cap $5.93B. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Not investment advice. Open the CROX and DVA stock pages for the full models.
Not investment advice.